Integer (NYSE:ITGR) Issues Earnings Results

Integer (NYSE:ITGR) issued its quarterly earnings data on Thursday. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03), Zacks reports. Integer had a net margin of 6.70% and a return on equity of 11.63%. Integer updated its FY 2025 guidance to 5.840-6.200 EPS.

Integer Price Performance

NYSE:ITGR traded down $3.95 during trading hours on Thursday, hitting $139.26. The company’s stock had a trading volume of 222,791 shares, compared to its average volume of 228,729. The business’s 50-day moving average is $137.98 and its two-hundred day moving average is $132.28. The company has a market capitalization of $4.67 billion, a PE ratio of 43.25, a PEG ratio of 1.80 and a beta of 1.13. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. Integer has a 52-week low of $97.49 and a 52-week high of $146.36.

Wall Street Analyst Weigh In

ITGR has been the subject of a number of research reports. Truist Financial boosted their price objective on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Wells Fargo & Company restated an “overweight” rating and set a $160.00 price target on shares of Integer in a research note on Tuesday, December 3rd. KeyCorp upped their price target on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Citigroup upped their price target on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. Finally, Piper Sandler restated an “overweight” rating and set a $140.00 price target (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. One analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $146.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.